REGISTERED NUMBER: 07181164 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 July 2017

for

AA Pharm Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

Chartered Accountants' Report

7

DIRECTORS:

A M Amin

M A Rafiq

REGISTERED OFFICE:

46-48 Duckworth Lane

Bradford

West Yorkshire

BD9 5HB

REGISTERED NUMBER:

07181164 (England and Wales)

ACCOUNTANTS:

M Cubed Chartered Accountants

9 De Montfort Street

Leicester

Leicestershire

LE1 7GE

FIXED ASSETS

Tangible assets

4

365,038

390,981

CURRENT ASSETS

Stocks

5

21,150

75,000

Debtors

6

330,912

334,349

Cash at bank and in hand

25,504

160,063

377,566

569,412

CREDITORS

Amounts falling due within one year

7

(307,058

)

(464,194

)

NET CURRENT ASSETS

70,508

105,218

TOTAL ASSETS LESS CURRENT LIABILITIES

435,546

496,199

CREDITORS

Amounts falling due after more than one year

8

(143,008

)

(194,736

)

PROVISIONS FOR LIABILITIES

(7,007

)

(11,310

)

NET ASSETS

285,531

290,153

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

285,431

290,053

SHAREHOLDERS' FUNDS

285,531

290,153

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2017.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2017 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 24 April 2018 and were signed on its behalf by:

A M Amin - Director

1.	STATUTORY INFORMATION

AA Pharm Limited is a private company, limited by shares , registered in England and Wales. The company's

registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,

value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

20% on cost

Fixtures and fittings

-

20% on cost

Motor vehicles

-

20% on cost

Computer equipment

-

20% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow

moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to

the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or

substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance

sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from

those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that

have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the

timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they

will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 20 (2016 - 20 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

Freehold

Plant and

and

property

machinery

fittings

£

£

£

COST

At 1 August 2016

and 31 July 2017

330,000

81,450

34,031

DEPRECIATION

At 1 August 2016

-

32,580

27,809

Charge for year

-

16,290

6,222

At 31 July 2017

-

48,870

34,031

NET BOOK VALUE

At 31 July 2017

330,000

32,580

-

At 31 July 2016

330,000

48,870

6,222

Motor

Computer

vehicles

equipment

Totals

£

£

£

COST

At 1 August 2016

and 31 July 2017

6,588

10,566

462,635

DEPRECIATION

At 1 August 2016

5,270

5,995

71,654

Charge for year

1,318

2,113

25,943

At 31 July 2017

6,588

8,108

97,597

NET BOOK VALUE

At 31 July 2017

-

2,458

365,038

At 31 July 2016

1,318

4,571

390,981

5.

STOCKS

31.7.17

31.7.16

£

£

Stocks

21,150

75,000

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.7.17

31.7.16

£

£

Trade debtors

217,084

206,454

VAT

110,446

122,429

Prepayments

3,382

5,466

330,912

334,349

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.7.17

31.7.16

£

£

Trade creditors

159,729

313,719

Tax

18,883

21,002

Social security and other taxes

2,743

508

Directors' current accounts

125,703

126,096

Accrued expenses

-

2,869

307,058

464,194

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.7.17

31.7.16

£

£

Bank loans - 1-2 years

29,730

29,730

Bank loans - 2-5 years

44,594

44,594

Bank loans more 5 yr by instal

68,684

120,412

143,008

194,736

Amounts falling due in more than five years:

Repayable by instalments

Bank loans more 5 yr by instal

68,684

120,412

9.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 July 2017 and 31 July 2016:

31.7.17

31.7.16

£

£

A M Amin and M A Rafiq

Balance outstanding at start of year

(126,096

)

(67,700

)

Amounts advanced

66,253

-

Amounts repaid

(65,860

)

(58,396

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

(125,703

)

(126,096

)

10.	ULTIMATE CONTROLLING PARTY

The company is under the control of the directors.

The following reproduces the text of the report prepared for the directors in respect of the company's annual

unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file

a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the

Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the

financial statements of AA Pharm Limited for the year ended 31 July 2017 which comprise the Income Statement,

Balance Sheet, and the related notes from the company's accounting records and from information and explanations you

have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of AA Pharm Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of AA Pharm Limited and state those matters that we have agreed to state to the Board of Directors of AA Pharm Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than AA Pharm Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that AA Pharm Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of AA Pharm Limited. You consider that AA Pharm Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of AA Pharm Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

M Cubed Chartered Accountants

9 De Montfort Street

Leicester

Leicestershire

LE1 7GE

24 April 2018